IDH1 and oligodendroglioma: In the case of a 58-year-old female with a newly diagnosed IDH-mutant grade 3 oligodendroglioma, with both enhancing and non-enhancing residual disease visible on postoperative MRI after a near-total resection, there was a strong consensus among clinicians in favour of further treatment beyond observation [Figure 9].